Phosphatidylinositol-4,5-biphosphate (PIP2) differentially regulates the interaction of human erythrocyte protein 4.1 (4.1R) with membrane proteins

被引:51
作者
An, Xiuli
Zhang, Xihui
Debnath, Gargi
Baines, Anthony J.
Mohandas, Narla
机构
[1] New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10021 USA
[2] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England
关键词
D O I
10.1021/bi060015v
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human erythrocyte protein 4.1 (4.1R) participates in organizing the plasma membrane by linking several surface-exposed transmembrane proteins to the internal cytoskeleton. In the present study, we characterized the interaction of 4.1R with phosphatidylinositol-4,5-bisphosphate (PIP2) and assessed the effect Of PIP2 on the interaction of 4.1R with membrane proteins. We found that 4.1R bound to PIP2-containing liposomes through its N-terminal 30 kDa membrane-binding domain and PIP2 binding induced a conformational change in this domain. Phosphatidylinositol-4-phosphate (PIP) was a less effective inducer of this conformational change, and phosphatidylinositol (PI) and inositol-1,4,5-phosphate (IP3) induced no change. Replacement of amino acids K63,64 and K265,266 by alanine abolished the interaction of the membrane-binding domain with PIP2. Importantly, binding Of PIP2 to 4.1R selectively modulated the ability of 4.1R to interact with its different binding partners. While PIP2 significantly enhanced the binding of 4.1R to glycophorin C (GPC), it inhibited the binding of 4.1R to band 3 in vitro. PIP2 had no effect on 4.1R binding to p55. Furthermore, GPC was more readily extracted by Titon X-100 from adenosine triphosphate (ATP)-depleted erythrocytes, implying that the GPC-4.1R interaction may be regulated by PIP2 in situ. These findings define an important role for PIP2 in regulating the function of 4.1R. Because 4.1R and its family members (4.1R, 4.1B, 4.1G, and 4.1N) are widely expressed and the PIP2-binding motifs are highly conserved, it is likely that the functions of other 4.1 proteins are similarly regulated by PIP2 in many different cell types.
引用
收藏
页码:5725 / 5732
页数:8
相关论文
共 37 条
  • [21] CALMODULIN MODULATES PROTEIN-4.1 BINDING TO HUMAN ERYTHROCYTE-MEMBRANES
    LOMBARDO, CR
    LOW, PS
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1994, 1196 (02): : 139 - 144
  • [22] Modulation of erythrocyte membrane mechanical function by protein 4.1 phosphorylation
    Manno, S
    Takakuwa, Y
    Mohandas, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (09) : 7581 - 7587
  • [23] MARFATIA SM, 1994, J BIOL CHEM, V269, P8631
  • [24] A nonerythroid isoform of protein 4.1R interacts with the nuclear mitotic apparatus (NuMA) protein
    Mattagajasingh, SN
    Huang, SC
    Hartenstein, JS
    Snyder, M
    Marchesi, VT
    Benz, EJ
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 145 (01) : 29 - 43
  • [25] Regulation of protein 4.1R, p55, and glycophorin C ternary complex in human erythrocyte membrane
    Nunomura, W
    Takakuwa, Y
    Parra, M
    Conboy, J
    Mohandas, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (32) : 24540 - 24546
  • [26] Ca2+-dependent and Ca2+-independent calmodulin binding sites in erythrocyte protein 4.1 -: Implications for regulation of protein 4.1 interactions with transmembrane proteins
    Nunomura, W
    Takakuwa, Y
    Parra, M
    Conboy, JG
    Mohandas, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (09) : 6360 - 6367
  • [27] Regulation of CD44-protein 4.1 interaction by Ca2+ and calmodulin - Implications for modulation of CD44-ankyrin interaction
    Nunomura, W
    Takakuwa, Y
    Tokimitsu, R
    Krauss, SW
    Kawashima, M
    Mohandas, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) : 30322 - 30328
  • [28] Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain
    Pearson, MA
    Reczek, D
    Bretscher, A
    Karplus, PA
    [J]. CELL, 2000, 101 (03) : 259 - 270
  • [29] REID ME, 1990, BLOOD, V75, P2229
  • [30] Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities
    Shi, ZT
    Afzal, V
    Coller, B
    Patel, D
    Chasis, JA
    Parra, M
    Lee, G
    Paszty, C
    Stevens, M
    Walensky, L
    Peters, LL
    Mohandas, N
    Rubin, E
    Conboy, JG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (03) : 331 - 340